Assessment |
Biopsychology |
Comparative |
Cognitive |
Developmental |
Language |
Individual differences |
Personality |
Philosophy |
Social |
Methods |
Statistics |
Clinical |
Educational |
Industrial |
Professional items |
World psychology |
Biological: Behavioural genetics · Evolutionary psychology · Neuroanatomy · Neurochemistry · Neuroendocrinology · Neuroscience · Psychoneuroimmunology · Physiological Psychology · Psychopharmacology (Index, Outline)
|
Pramiracetam chemical structure | |
| N-[2-(dipropan-2-ylamino)ethyl]-2-(2-oxopyrrolidin-1-yl)acetamide IUPAC name | |
| CAS number [1] |
ATC code [[ATC_code_|]][2] |
| PubChem 51712 |
DrugBank [3] |
| Chemical formula | {{{chemical_formula}}} |
| Molecular weight | 269.383 g/mol |
| Bioavailability | |
| Metabolism | |
| Elimination half-life | |
| Excretion | |
| Pregnancy category | |
| Legal status | Unscheduled (US) |
| Routes of administration | Oral |
Pramiracetam is a nootropic drug derived from piracetam, and is more potent (i.e. lower dosage is used). It belongs to the racetam family of nootropics.
Pramiracetam was developed by Parke-Davis based on Piracetam, and is 8-30 times stronger than Piracetam. It goes by the trade name Neupramir or Pramistar.
External links[]
- Nootropics - Reviewing The Smart-Drugs, By James South, MA
- The Cognitive Enhancement Research Institute
- de:Pramiracetam
- fi:Pramirasetaami
| This page uses Creative Commons Licensed content from Wikipedia (view authors). |